HIV and pandemic influenza virus: two great infectious disease challenges

Overview of vaccines.

Methods in molecular medicine·2011

Progress towards achieving new vaccine and vaccination goals.

Internal medicine journal·2003

Carbohydrate-protein conjugate vaccines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2003

The coming of age of tumour immunotherapy.

Immunology and cell biology·1999

Overview of vaccines.

Molecular biotechnology·1997

Do cytotoxic T lymphocytes clear some HIV/SIV infections?

Journal of medical primatology·1996

No receptor-binding domain adaptation detected in within-host H5N1 surveillance of 4,559 US dairy outbreak sequences.

Virology·2026

Evaluating sampling strategies for the detection of avian influenza viruses in the environment.

Virology·2026

Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.

Virology·2026

In-depth comparison of dengue virus laboratory strains and clinical isolates in terms of growth properties and NS1 production and detection in hepatic and non-hepatic cell lines.

Virology·2026

Single-cell transcriptomic landscape of avian influenza H9N2 virus infection in human and chicken cells.

Virology·2026

HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type α2,6-linked sialic acid receptors.

Virology·2026

Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease.

Annals of medicine·2026

Measurement Invariance of the Brief State Rumination Inventory Across Administration Methods, National Samples, and Sex.

Journal of personality assessment·2026

Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.

Journal of medical virology·2026

Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review.

Journal of nutrition and metabolism·2026

Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.

International journal of nanomedicine·2026

Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India.

Indian journal of clinical biochemistry : IJCB·2026

Related Experiment Videos

HIV and pandemic influenza virus: two great infectious disease challenges

Related Concept Videos

Overview of vaccines.

Progress towards achieving new vaccine and vaccination goals.

Carbohydrate-protein conjugate vaccines.

The coming of age of tumour immunotherapy.

Overview of vaccines.

Do cytotoxic T lymphocytes clear some HIV/SIV infections?

No receptor-binding domain adaptation detected in within-host H5N1 surveillance of 4,559 US dairy outbreak sequences.

Evaluating sampling strategies for the detection of avian influenza viruses in the environment.

Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.

In-depth comparison of dengue virus laboratory strains and clinical isolates in terms of growth properties and NS1 production and detection in hepatic and non-hepatic cell lines.

Single-cell transcriptomic landscape of avian influenza H9N2 virus infection in human and chicken cells.

HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type α2,6-linked sialic acid receptors.

Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease.

Measurement Invariance of the Brief State Rumination Inventory Across Administration Methods, National Samples, and Sex.

Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran.

Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review.

Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.

Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India.

Related Experiment Videos

HIV and pandemic influenza virus: two great infectious disease challenges

Related Concept Videos

Related Articles